Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reaction
Aromatase inhibitors' possible neurodegenerative effects need study
May 12th, 2005
According to a recent article in Geburtshilfe und Frauenheilkunde, "Impressive successes have been achieved with the possibilities offered by the endocrinal treatment of metastasizing breast cancer. "Adjuvant endocrinal therapy is presently undergoing a change. Should we continue to prescribe tamoxifen as we have been doing for the past 30 years, or should we resort to administering aromatase inhibitors for up to 5 or more years' Before initiating a large-scale change we should make every effort to find out whether there would be any long-term adverse effects on the central nervous system," wrote J.M. Wenderlein and colleagues, University of Ulm. ...
Source: Women's Health Weekly (2005-05-12)
|
